This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Regulatory Affairs, Medical Devices
search

Understanding how ISO 10993-17 and ISO 10993-18 connect - WHITEPAPER

ArticleImage

Download the exclusive whitepaper

Risk assessment is a key component in the approval process for a new medical device. The International Organization for Standardization (ISO) 10993 series of standards is recognized by
regulatory bodies throughout the world and applies when a medical device comes into contact with the body directly or indirectly. Both ISO 10993-17/18 should be considered in the context of the ISO 10993-1: evaluation and testing within a risk management process. ISO 10993 guides the assessment of medical devices on tissues in a general way. For a complete biological safety evaluation, it classifies medical devices according to the nature and duration of their use and indicates the data sets that are relevant.

This whitepaper discusses ISO 10993-17/18, how they relate, and considerations for industry.

To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

This piece represents the views of the author and not necessarily the views of Informa Connect Life Sciences or the Biocompatibility for Medical Devices conference series.

Log in or Create an Informa Connect Account to Access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.